Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
EDAP [NASD]
EDAP TMS SA
Index- P/E- EPS (ttm)-0.02 Insider Own3.75% Shs Outstand24.80M Perf Week-28.21%
Market Cap91.51M Forward P/E184.50 EPS next Y0.02 Insider Trans- Shs Float12.42M Perf Month-16.89%
Income-0.40M PEG- EPS next Q-0.06 Inst Own25.40% Short Float12.64% Perf Quarter16.40%
Sales34.80M P/S2.63 EPS this Y43.10% Inst Trans45.74% Short Ratio3.03 Perf Half Y19.42%
Book/sh0.58 P/B6.36 EPS next Y128.60% ROA-1.30% Target Price6.00 Perf Year29.93%
Cash/sh0.42 P/C8.72 EPS next 5Y3.00% ROE-4.10% 52W Range2.38 - 6.05 Perf YTD25.08%
Dividend- P/FCF- EPS past 5Y-28.50% ROI-18.10% 52W High-39.01% Beta2.31
Dividend %- Quick Ratio1.50 Sales past 5Y0.80% Gross Margin41.10% 52W Low55.04% ATR0.41
Employees154 Current Ratio1.90 Sales Q/Q30.90% Oper. Margin-4.00% RSI (14)31.76 Volatility13.67% 8.97%
OptionableYes Debt/Eq0.71 EPS Q/Q117.90% Profit Margin-1.40% Rel Volume2.51 Prev Close3.65
ShortableYes LT Debt/Eq0.44 EarningsMay 12 Payout- Avg Volume518.51K Price3.69
Recom2.00 SMA20-30.30% SMA50-15.22% SMA20010.41% Volume1,302,031 Change1.10%
28-Jul-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
16-Jun-14Initiated H.C. Wainwright Buy $6
05-Mar-13Initiated Northland Capital Outperform $6
18-Nov-10Reiterated Morgan Joseph Buy $3 → $5.25
20-Aug-09Reiterated Roth Capital Hold $2.50 → $5
24-Nov-08Reiterated Roth Capital Hold $2.50
26-Mar-08Reiterated Roth Capital Hold $6 → $4.50
09-Nov-07Reiterated Roth Capital Hold $7 → $6
16-Mar-07Reiterated Roth Capital Hold $8.50 → $7
24-Jan-07Reiterated Roth Capital Hold $6.50 → $8.50
28-Jul-14 03:11PM  EDAP TMS SA downgraded by Northland Capital Briefing.com -25.20%
27-Jun-14 08:30AM  EDAP Completes FDA Inspection of Manufacturing Site GlobeNewswire
08:30AM  EDAP Completes FDA Inspection of Manufacturing Site
16-Jun-14 07:14AM  Coverage initiated on EDAP TMS SA by H.C. Wainwright Briefing.com
07:14AM  Coverage initiated on EDAP TMS SA by H.C. Wainwright
03-Jun-14 08:30AM  EDAP Closes $9.3 Million Registered Direct Offering GlobeNewswire
08:30AM  EDAP Closes $9.3 Million Registered Direct Offering
28-May-14 08:56AM  EDAP to Raise $9.3 Million in Registered Direct Offering GlobeNewswire -5.16%
08:56AM  EDAP to Raise $9.3 Million in Registered Direct Offering
27-May-14 08:53AM  EDAP details additional milestones in Ablatherm-HIFU PMA process at theflyonthewall.com
08:53AM  EDAP details additional milestones in Ablatherm-HIFU PMA process
08:30AM  EDAP Outlines Key Events Scheduled in the Ablatherm-HIFU PMA Process GlobeNewswire
08:30AM  EDAP Outlines Key Events Scheduled in the Ablatherm-HIFU PMA Process
22-May-14 08:30AM  EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014 GlobeNewswire
08:30AM  EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014
16-May-14 08:30AM  EDAP Highlights Its HIFU and Lithotripsy Technologies at 109th Annual AUA Meeting GlobeNewswire
08:30AM  EDAP Highlights Its HIFU and Lithotripsy Technologies at 109th Annual AUA Meeting
15-May-14 02:22PM  EDAP TMS' (EDAP) CEO Marc Oczachowski on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
02:22PM  EDAP TMS' (EDAP) CEO Marc Oczachowski on Q1 2014 Results - Earnings Call Transcript
08:25AM  EDAP TMS S.A. (EDAP) Q1 2014 Results - Earnings Call Webcast at Seeking Alpha
08:25AM  EDAP TMS S.A. (EDAP) Q1 2014 Results - Earnings Call Webcast
07:36AM  EDAP TMS reports Q1 EPS 5c, one estimate (4c) at theflyonthewall.com
07:36AM  EDAP TMS reports Q1 EPS 5c, one estimate (4c)
07:30AM  EDAP Reports First Quarter 2014 Results GlobeNewswire
06-May-14 08:30AM  EDAP Announces First Focal One(R) HIFU Treatments Performed in Germany GlobeNewswire
01-May-14 08:30AM  EDAP Schedules Webcast and Conference Call for First Quarter 2014 Results GlobeNewswire
24-Apr-14 08:30AM  EDAP Announces European Association of Urology Recommends HIFU for Treatment of Localized Prostate Cancer GlobeNewswire
21-Apr-14 08:30AM  EDAP Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health GlobeNewswire
10-Apr-14 08:30AM  EDAP's HIFU and Lithotripsy Devices Highlighted at 29th Annual EAU Congress GlobeNewswire
09-Apr-14 01:04PM  EDAP TMS SA Financials EDGAR Online Financials
03-Apr-14 12:08PM  EDAP's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha +6.31%
08:30AM  Edap TMS SA Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  EDAP TMS S.A. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
07:34AM  Edap TMS SA Earnings Call scheduled for 8:30 am ET today CCBN
07:30AM  EDAP Reports Fourth Quarter 2013 and Full Year Results GlobeNewswire
07:07AM  Q4 2013 Edap TMS SA Earnings Release - Before Market Open CCBN
20-Mar-14 09:37AM  EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application GlobeNewswire
11-Feb-14 08:30AM  EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland GlobeNewswire
10-Feb-14 08:41AM  EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2013 Results GlobeNewswire
09-Dec-13 07:18PM  EDAP TMS: 2014 FDA Decision On Treatment For Prostate Cancer Could Bring Attractive Gains at Seeking Alpha
07:18PM  EDAP TMS: 2014 FDA Decision On Treatment For Prostate Cancer Could Bring Attractive Gains
21-Nov-13 10:40AM  EDAP TMS's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
10:40AM  EDAP TMS's CEO Discusses Q3 2013 Results - Earnings Call Transcript
07:30AM  EDAP Reports Third Quarter 2013 Results GlobeNewswire
07:30AM  EDAP Reports Third Quarter 2013 Results
07:07AM  Q3 2013 Edap TMS SA Earnings Release - Before Market Open CCBN
07:07AM  Q3 2013 Edap TMS SA Earnings Release - Before Market Open
31-Oct-13 08:30AM  EDAP Schedules Webcast and Conference Call for Third Quarter 2013 Results GlobeNewswire
08:30AM  EDAP Schedules Webcast and Conference Call for Third Quarter 2013 Results
22-Oct-13 09:00AM  EDAP's Ablatherm-HIFU to be Showcased at 31st World Congress of Endourology GlobeNewswire
09:00AM  EDAP's Ablatherm-HIFU to be Showcased at 31st World Congress of Endourology
28-Aug-13 11:12AM  EDAP's CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha -6.92%
11:12AM  EDAP's CEO Discusses Q2 2013 Results - Earnings Call Transcript
07:30AM  EDAP Reports Second Quarter 2013 Results GlobeNewswire
07:07AM  Q2 2013 Edap TMS Earnings Release - Before Market Open CCBN
26-Aug-13 09:53AM  CORRECTING AND REPLACING -- EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co. GlobeNewswire
08:30AM  EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co. GlobeNewswire
13-Aug-13 08:30AM  EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results GlobeNewswire
18-Jun-13 09:09AM  InPlay: EDAP TMS SA granted european market clearance for Focal One Briefing.com +7.84%
09:01AM  EDAP Granted European Market Clearance for Focal.One(R) GlobeNewswire
14-Jun-13 09:01AM  InPlay: EDAP fully redeems $8.0 mln long-term debt Briefing.com -14.40%
09:00AM  EDAP Fully Redeems $8.0 Million Long-Term Debt GlobeNewswire
29-May-13 09:01AM  EDAP Significantly Strengthens Financial Profile GlobeNewswire
21-May-13 09:01AM  InPlay: EDAP TMS SA entered into definitive agreements with certain institutional investors for registered direct placement of $12 mln of ordinary shares in form of ADSs at price of $4.00/share, with warrants attached Briefing.com -8.56%
09:00AM  EDAP to Raise $12 Million in Registered Direct Offering GlobeNewswire
20-May-13 09:27AM  InPlay: EDAP TMS SA's Ablatherm-HIFU demonstrates long term efficacy, durability and reproducibility with prospective fourteen -year study Briefing.com +6.22%
09:25AM  EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study GlobeNewswire
16-May-13 01:00PM  Edap TMS CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
01:00PM  Edap TMS CEO Discusses Q1 2013 Results - Earnings Call Transcript
07:30AM  EDAP Reports 23% Increase in First Quarter 2013 Revenues GlobeNewswire
07:07AM  Q1 2013 Edap TMS Earnings Release - Before Market Open CCBN
14-May-13 09:00AM  EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting GlobeNewswire
13-May-13 02:45PM  EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results GlobeNewswire
01-May-13 09:21AM  EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting GlobeNewswire
30-Apr-13 02:55PM  5 Health Care Stocks Under $10 to Watch at TheStreet
02:55PM  5 Health Care Stocks Under $10 to Watch
11-Apr-13 08:30AM  EDAP Announces 23% First Quarter 2013 Revenue Growth GlobeNewswire
06-Apr-13 01:04PM  EDAP TMS SA Financials EDGAR Online Financials
01:04PM  EDAP TMS SA Financials
02-Apr-13 07:07AM  Q4 2012 Edap TMS Earnings Release - Before Market Open CCBN
07:00AM  EDAP Reports Fourth Quarter 2012 and Full Year Results GlobeNewswire
28-Mar-13 08:49AM  EDAP receives FDA filing acceptance of pre-market approval application at theflyonthewall.com
08:49AM  EDAP receives FDA filing acceptance of pre-market approval application
08:48AM  InPlay: EDAP TMS SA receives FDA filing acceptance of pre-market approval application Briefing.com
08:45AM  EDAP Receives U.S. FDA Filing Acceptance of Pre-Market Approval Application GlobeNewswire
14-Mar-13 08:30AM  EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer GlobeNewswire +7.44%
12-Mar-13 08:30AM  EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2012 Results GlobeNewswire -5.62%
08-Mar-13 04:42PM  4 Healthcare Stock Stories Not To Be Overlooked on TGIF at Wall St. Cheat Sheet
04:42PM  4 Healthcare Stock Stories Not To Be Overlooked on TGIF
07-Mar-13 08:32AM  InPlay: EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm-HIFU Pre-Market Approval Application Briefing.com +7.89%
08:32AM  InPlay: EDAP receives U.S. FDA administrative acceptance review notification for Ablatherm-HIFU pre-market approval application Briefing.com
08:30AM  EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm(R)-HIFU Pre-Market Approval Application GlobeNewswire
05-Mar-13 04:48PM  New Source Energy Still at Outperform and 3 Reiterated Ratings to Know Now at Wall St. Cheat Sheet
04-Mar-13 08:58PM  Coverage initiated on EDAP TMS SA by Northland Capital Briefing.com
26-Feb-13 10:44AM  EDAP Prepares Prostate Cancer System For U.S. Market at Seeking Alpha +6.85%
25-Feb-13 01:23PM  EDAP: The Holy Grail In The Fight Against Prostate Cancer at Seeking Alpha +19.59%
08:39AM  Barnes to be Acquired by MSC and 3 Stocks Hitting 52-Week Highs at Wall St. Cheat Sheet
22-Feb-13 08:30AM  EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer GlobeNewswire +18.34%
14-Feb-13 01:09PM  5 Stocks Under $10 Set to Explode at TheStreet
08-Feb-13 09:32AM  InPlay: EDAP TMS SA announced before the open new data demonstrating the safety and long-term efficacy of Ablatherm-HIFU; findings included favorable oncological outcomes with biochemical disease-free survival rates Briefing.com
EDAP TMS S.A., through its subsidiaries, develops, produces, and markets minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services. The High Intensity Focused Ultrasound division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It also offers Ablatherm, a HIFU-based device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. In addition, this division leases equipment; sells disposables and spare parts; and offers maintenance services. The Urology Devices and Service division develops, markets, manufactures, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of ESWL technology. In addition, this division is engaged in the leasing of lithotripters; sale of disposables and spare parts; and provision of maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.